SCHEMBL1256374

SCHEMBL1256374

CCn1ccc(-c2sc(N)nc2-c2ccco2)cc1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 3/20 0.54
HSD17B10 Q99714 2/20 0.54
MEN1 O00255 2/20 0.54
POLB P06746 2/20 0.54
BLM P54132 2/20 0.54
PKM P14618 1/20 0.54
ALOX15 P16050 1/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
PIK3CD O00329 3/20 0.52
PIK3CA P42336 3/20 0.52
PI4KA P42356 3/20 0.52
PI4KB Q9UBF8 3/20 0.52
PIK3CG P48736 2/20 0.52
PIK3CB P42338 2/20 0.52
FBP1 P09467 4/20 0.43
ADORA2A P29274 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1254076 0.86 HSD17B10 (0.51) ALDH1A1KMT2AMAPTHSD17B10MEN1
SCHEMBL1256209 0.85 MAPT (0.58) ALDH1A1KMT2AMAPTHSD17B10MEN1
SCHEMBL1255469 0.83 ALDH1A1 (0.55) ALDH1A1KMT2AMAPTHSD17B10MEN1
SCHEMBL1255677 0.81 TSHR (0.47) ALDH1A1KMT2AMAPTHSD17B10MEN1
SCHEMBL3455186 0.81 ADORA2A (0.48) PIK3CDPIK3CAPI4KAPI4KBPIK3CG
SCHEMBL1255664 0.77 L3MBTL1 (0.51) ALDH1A1KMT2AMAPTMEN1POLB
SCHEMBL27668379 0.77 ALDH1A1 (0.53) ALDH1A1KMT2AMAPTHSD17B10MEN1
SCHEMBL3457651 0.77 ADORA2A (0.61) PIK3CDPIK3CAPI4KAPI4KBPIK3CG
SCHEMBL1256398 0.76 ALDH1A1 (0.56) ALDH1A1KMT2AMAPTHSD17B10MEN1
SCHEMBL1256165 0.75 ADORA2B (0.60) ALDH1A1KMT2AMAPTHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3002283-B1 THIAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO LTD (JP) 2017-06-14 EP disclosed
EP-3002283-A1 THIAZOLE DERIVATIVES Kyowa Hakko Kirin Co., Ltd. (JP) 2016-04-06 EP disclosed
EP-1700856-B1 THIAZOLE DERIVATIVE KYOWA HAKKO KIRIN CO LTD (JP) 2015-11-11 EP disclosed
US-8889718-B2 Thiazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-11-18 US disclosed
US-20130267509-A1 THIAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-10-10 US disclosed
US-8420827-B2 Thiazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-04-16 US disclosed
US-20110105486-A1 THIAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-05-05 US disclosed
US-7880013-B2 Thiazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-02-01 US disclosed
CN-1902196-B Thiazole derivatives KYOWA HAKKO KOGYO KK 2010-12-29 CN disclosed
US-20100256361-A1 THIAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
US-7718808-B2 Thiazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-05-18 US disclosed
US-20070105919-A1 adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-05-10 US disclosed
CN-1902196-A Thiazole derivatives KYOWA HAKKO KOGYO KK (JP) 2007-01-24 CN disclosed
EP-1700856-A1 THIAZOLE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267509-A1 THIAZOLE DERIVATIVES THRA, CHD8, CYP2C8 ALDH1A1 1344/4885KMT2A 992/4885MAPT 1492/4885
US-20110105486-A1 THIAZOLE DERIVATIVES CHD8, CYP2C8, THRA ALDH1A1 769/4885KMT2A 1022/4885MAPT 4205/4885
US-20100256361-A1 THIAZOLE DERIVATIVES ADORA2A, ADORA3, ADORA1 ALDH1A1 1290/4885KMT2A 4222/4885MAPT 4006/4885
US-20070105919-A1 adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders ADORA2A, ADORA3, ADORA1 ALDH1A1 2843/4885KMT2A 3885/4885MAPT 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.